NMO occupies a unique position in the spectrum of inflammatory central nervous system demyelinating disorders in that it is the only such disorder that has an associated disease-specific antibody, aquaporin-4 antibody (AQP4 Ab), or NMO-IgG. This evidence concerns the gene AQP4 and neuromyelitis optica.